A PHASE-II TRIAL OF BISANTRENE (CL216,942) IN REFRACTORY EPITHELIAL OVARIAN-CANCER

被引：0
|
作者：
KAVANAGH, JJ
GERSHENSON, DM
SAUL, PB
COPELAND, LJ
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT GYNECOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT CHEMOTHERAPY RES,HOUSTON,TX 77030
来源：
GYNECOLOGIC ONCOLOGY | 1986年 / 23卷 / 01期
关键词：
D O I：
10.1016/0090-8258(86)90113-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：40 / 43
页数：4
相关论文
共 50 条
  • [21] PHASE-I PHASE-II STUDY OF INTRAPERITONEAL MITOXANTRONE IN REFRACTORY OVARIAN-CANCER
    OZA, AM
    HUININK, WT
    DUBBELMAN, R
    SOEPENBERG, O
    MANDJES, I
    AARTSEN, E
    MCVIE, JG
    ANNALS OF ONCOLOGY, 1994, 5 (04) : 343 - 347
  • [22] A PHASE-II CLINICAL-TRIAL OF CARBOPLATIN IN ADVANCED OVARIAN-CANCER
    POHL, J
    MEERPOHL, HG
    PFLEIDERER, A
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (01) : 61 - 61
  • [23] VERAPAMIL WITH MITOXANTRONE FOR ADVANCED OVARIAN-CANCER - A NEGATIVE PHASE-II TRIAL
    HENDRICK, AM
    HARRIS, AL
    CANTWELL, BMJ
    ANNALS OF ONCOLOGY, 1991, 2 (01) : 71 - 72
  • [24] PHASE-II EVALUATION OF MITOZOLOMIDE IN OVARIAN-CANCER
    HARDING, M
    NORTHCOTT, D
    SMYTH, J
    STUART, NSA
    GREEN, JA
    NEWLANDS, E
    BRITISH JOURNAL OF CANCER, 1988, 57 (01) : 113 - 114
  • [25] A PHASE-II STUDY OF TAMOXIFEN IN OVARIAN-CANCER
    SLEVIN, ML
    HARVEY, VJ
    OSBORNE, RJ
    SHEPHERD, JH
    WILLIAMS, CJ
    MEAD, GM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (03): : 309 - 312
  • [26] A PHASE-II STUDY OF SULOFENUR, A NOVEL SULFONYLUREA, IN RECURRENT EPITHELIAL OVARIAN-CANCER
    OBRIEN, MER
    HARDY, J
    TAN, S
    WALLING, J
    PETERS, B
    HATTY, S
    WILTSHAW, E
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 30 (03) : 245 - 248
  • [27] PHASE-II CLINICAL-TRIAL OF DOXIFLURIDINE IN PATIENTS WITH ADVANCED OVARIAN-CANCER
    VANOOSTEROM, AT
    HUININK, WWT
    VANDERBURG, MEL
    VERMORKEN, JB
    WILLEMSE, PHB
    NEIJT, JP
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (06) : 747 - 749
  • [28] TREATMENT OF OVARIAN-CANCER - PHASE-II TRIAL OF HIGH-DOSE CISPLATIN
    DORVAL, T
    BEUZEBOC, P
    GARCIAGIRALT, E
    JOUVE, M
    LIVARTOWSKI, A
    PALANGIE, T
    POUILLART, P
    PRESSE MEDICALE, 1993, 22 (03): : 104 - 108
  • [29] PHASE-II TRIAL OF 9,10 ANTHRACENEDICARBOXALDEHYDE BIS ((4,5 DIHYDRO-1 H IMIDAZOL-2-YL)HYDRAZONE) DIHYDROCHLORIDE (CL216,942) FOR METASTATIC HYPER-NEPHROMA
    SCHER, H
    SCHWARTZ, S
    YAGODA, A
    WATSON, RC
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 145 - 145
  • [30] BISANTRENE (NSC 337766) (CL 216,942) IN ADVANCED BREAST-CANCER - A CANCER AND LEUKEMIA GROUP-B STUDY
    FORASTIERE, AA
    PERRY, MC
    HUGHES, AK
    WOOD, WC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) : 226 - 229
12345